secwatch / observer
SSKN STRATA Skin Sciences, Inc.
CIK 0001051514 50 ready 8-Ks latest February 11, 2026, 6:59 PM ET RSS · JSON
Activity: QUIET 0 filings / 30d vs 1 baseline
Ready 8-Ks 50
Latest filing February 11, 2026, 6:59 PM ET
Top materiality 0.90
Event mix earnings ×15 · other_material ×14 · other ×7
Sentiment 21 pos · 9 neg · 20 neu
Latest earnings reported 2025-Q3
Executive change recent →
SHENANIGAN SCORE 2 / 7 see the board

Recent 8-K filings for SSKN

Highest-materiality recent filing

Strata Skin Sciences to be delisted from Nasdaq on Feb 19 after failing equity requirement

February 11, 2026, 6:59 PM ET other material materiality 0.90 negative item 3.01item 8.01

Read filing →

Executive changes

Appointed

John Gillings

principal financial officer and principal accounting officer
SSKN · STRATA Skin Sciences, Inc.
Effective
2024-11-13
Filed
November 13, 2024, 6:59 PM ET
On November 13, 2024, Strata Skin Sciences, Inc. (the “Company”) designated its Vice President Finance, John Gillings, as its principal financial officer and principal accounting officer.
Role change

Shmuel Gov

Chief Operating Officer
SSKN · STRATA Skin Sciences, Inc.
Effective
2023-11-14
Filed
November 15, 2023, 6:59 PM ET
On November 14, 2023 the Board of Directors of Strata Skin Sciences, Inc. (the “Company”) approved the promotion of Shmuel Gov to the position of Chief Operating Officer.
Departed

Robert Moccia

Member of the Board of Directors
SSKN · STRATA Skin Sciences, Inc.
Effective
2023-10-30
Filed
October 30, 2023, 7:59 PM ET
Moccia resigned as the Company’s Chief Executive Officer and President and as a member of the Company’s board of directors.
Departed

Robert Moccia

Chief Executive Officer and President
SSKN · STRATA Skin Sciences, Inc.
Effective
2023-10-30
Successor
Dolev Rafaeli
Filed
October 30, 2023, 7:59 PM ET
Moccia resigned as the Company’s Chief Executive Officer and President and as a member of the Company’s board of directors.
Appointed

Dolev Rafaeli

Vice-Chairman of the Board, President and Chief Executive Officer
SSKN · STRATA Skin Sciences, Inc.
Effective
2023-10-30
Filed
October 30, 2023, 7:59 PM ET
the Company appointed Dr. Dolev Rafaeli, PhD, (“Rafaeli”), as its Vice-Chairman of the Board, President and Chief Executive Officer.
Appointed

Patricia S. Walker, M.D., Ph.D.

member of the Board of Directors
SSKN · STRATA Skin Sciences, Inc.
Effective
2022-02-14
Filed
February 14, 2022, 6:59 PM ET
the Board of Directors of Strata Skin Sciences, Inc. (the “Company”) appointed Patricia S. Walker M.D., Ph.D. to serve as a member of the Company’s Board of Directors
Departed

LuAnn Via

Board member, Vice Chairperson, and Chair of the Board's Audit Committee
SSKN · STRATA Skin Sciences, Inc.
Effective
2021-12-31
Successor
Douglas Strang
Filed
December 9, 2021, 6:59 PM ET
LuAnn Via submitted her letter of resignation, effective December 31, 2021, from her position as a Board member, Vice Chairperson, and Chair of the Board's Audit Committee of Strata Skin Sciences, Inc.
Role change

Douglas Strang

Chair of the Audit Committee
SSKN · STRATA Skin Sciences, Inc.
Effective
2021-12-31
Filed
December 9, 2021, 6:59 PM ET
Douglas Strang, a member of the Company's Board and a member of the Audit Committee, agreed to serve as Chair of the Audit Committee effective upon Ms. Via’s resignation.
Appointed

Douglas S. Strang

Director
SSKN · STRATA Skin Sciences, Inc.
Effective
2021-10-27
Filed
October 28, 2021, 7:59 PM ET
On October 27, 2021, based upon the recommendation of the Nominating and Governance Committee, the Board of Directors of Strata Skin Sciences, Inc. (the “Company”) appointed Douglas S. Strang to serve as a member of the Company’s Board of Directors until the earlier of Mr. Strang’s resignation or his successor has been elected and qualified.
Appointed

Christopher Lesovitz

Chief Financial Officer
SSKN · STRATA Skin Sciences, Inc.
Effective
2021-10-16
Filed
October 4, 2021, 7:59 PM ET
Effective October 16, 2021, the Company appointed Christopher Lesovitz (age 39) as its Chief Financial Officer.
Departed

Matthew C. Hill

Chief Financial Officer
SSKN · STRATA Skin Sciences, Inc.
Effective
2021-10-15
Successor
Christopher Lesovitz
Filed
October 4, 2021, 7:59 PM ET
On October 4, 2021, Matthew C. Hill, the Company’s Chief Financial Officer, notified the Company of his resignation effective October 15, 2021.

Earnings & guidance

2025-Q3 EPS reported -$1.48 filing →

Materiality & sentiment trend

Max materiality 0.90 · Median 0.65 · Most common event earnings

21 positive 9 negative 20 neutral

source · SSKN on sec.gov